Full remission in a patient with catheter-associated ventriculitis due to Acinetobacter baumannii treated with intrathecal and intravenous colistin besides coinfections with other multidrug-resistant bacteria

Neurological Sciences

Volumn 36, Issue 4, 2015, Pages 633-634

  Dersch, Rick ^a   Robinson, E ^a   Beume, L ^a   Rauer, S ^a   Niesen, W D ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; COLISTIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; CASE REPORT; CEREBRAL VENTRICULITIS; COMPLICATION; DRUG EFFECTS; HUMAN; MALE; MIDDLE AGED; MIXED INFECTION; MULTIDRUG RESISTANCE; TREATMENT OUTCOME;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CEREBRAL VENTRICULITIS; COINFECTION; COLISTIN; DRUG RESISTANCE, MULTIPLE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84939966740     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-014-2031-y     Document Type: Letter

References (10)

1. Vincent JL et al (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302(21):2323–2329
2. Rodriguez Guardado A et al (2008) Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother 61(4):908–913
3. Jin L et al (2009) Brain penetration of colistin in mice assessed by a novel high-performance liquid chromatographic technique. Antimicrob Agents Chemother 53(10):4247–4251
4. Cascio A et al (2010) Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature. Int J Infect Dis 14(7):e572–e579
5. De Pascale G et al (2010) Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intrathecal and intravenous colistin. Minerva Anestesiol 76(11):957–960
6. Ho YH et al (2007) Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin. J Microbiol Immunol Infect 40(6):537–540
7. Khawcharoenporn T, Apisarnthanarak A, Mundy LM (2010) Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review. Clin Microbiol Infect 16(7):888–894
8. Ng J et al (2006) Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review. J Antimicrob Chemother 58(5):1078–1081
9. Vasen W et al (2000) Intrathecal use of colistin. J Clin Microbiol 38(9):3523
10. Schulte B et al (2005) Clonal spread of meropenem-resistant Acinetobacter baumannii strains in hospitals in the Mediterranean region and transmission to South-west Germany. J Hosp Infect 61(4):356–357